Vo J, Franson A, Waszak S, Wu Y, Becker N, Chinnaiyan A
Acta Neuropathol Commun. 2024; 12(1):195.
PMID: 39707575
PMC: 11662563.
DOI: 10.1186/s40478-024-01896-8.
Subramanyan L, Rasheed S, Wang L, Ghosh S, Ong M, Lakshmanan M
Breast Cancer Res. 2024; 26(1):113.
PMID: 38965558
PMC: 11225210.
DOI: 10.1186/s13058-024-01866-x.
Zhou J, Tang C
Curr Vasc Pharmacol. 2024; 22(2):95-105.
PMID: 38284693
DOI: 10.2174/0115701611258090231221082502.
Wallbillich N, Lu H
Chin Med J Pulm Crit Care Med. 2023; 1(3):129-138.
PMID: 37920609
PMC: 10621893.
DOI: 10.1016/j.pccm.2023.07.001.
Cheng X, Yang W, Lin W, Mei F
Pharmacol Rev. 2023; 75(5):979-1006.
PMID: 37137717
PMC: 10441629.
DOI: 10.1124/pharmrev.122.000784.
Altered vitamin B12 metabolism in the central nervous system is associated with the modification of ribosomal gene expression: new insights from comparative RNA dataset analysis.
Mathew A, Cavallucci V, Fidaleo M
Funct Integr Genomics. 2023; 23(1):45.
PMID: 36683116
PMC: 9868042.
DOI: 10.1007/s10142-023-00969-6.
High-Level Amplified Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures.
Roohollahi K, de Jong Y, van Mil S, Fabius A, Moll A, Dorsman J
Ophthalmol Sci. 2022; 2(3):100188.
PMID: 36245757
PMC: 9559112.
DOI: 10.1016/j.xops.2022.100188.
Heterogeneity of the NIH3T3 Fibroblast Cell Line.
Rahimi A, Cai M, Hoyer-Fender S
Cells. 2022; 11(17).
PMID: 36078083
PMC: 9455036.
DOI: 10.3390/cells11172677.
S146L in MYC is a context-dependent activating substitution in cancer development.
Hinds J, Feris E, Wilkins O, Deary L, Wang X, Cole M
PLoS One. 2022; 17(8):e0272771.
PMID: 36018850
PMC: 9417018.
DOI: 10.1371/journal.pone.0272771.
MYC: a complex problem.
Das S, Lewis B, Levens D
Trends Cell Biol. 2022; 33(3):235-246.
PMID: 35963793
PMC: 9911561.
DOI: 10.1016/j.tcb.2022.07.006.
MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging.
Grieb B, Eischen C
Biology (Basel). 2022; 11(6).
PMID: 35741402
PMC: 9219613.
DOI: 10.3390/biology11060881.
Venetoclax enhances DNA damage induced by XPO1 inhibitors: A novel mechanism underlying the synergistic antileukaemic effect in acute myeloid leukaemia.
Yu H, Wu S, Liu S, Li X, Gai Y, Lin H
J Cell Mol Med. 2022; 26(9):2646-2657.
PMID: 35355406
PMC: 9077288.
DOI: 10.1111/jcmm.17274.
Regulation of Nucleolar Activity by MYC.
Brown I, Lafita-Navarro M, Conacci-Sorrell M
Cells. 2022; 11(3).
PMID: 35159381
PMC: 8834138.
DOI: 10.3390/cells11030574.
Mutations in Hcfc1 and Ronin result in an inborn error of cobalamin metabolism and ribosomopathy.
Chern T, Achilleos A, Tong X, Hill M, Saltzman A, Reineke L
Nat Commun. 2022; 13(1):134.
PMID: 35013307
PMC: 8748873.
DOI: 10.1038/s41467-021-27759-7.
Relaxed initiation pausing of ribosomes drives oncogenic translation.
Dong L, Mao Y, Zhou A, Liu X, Zhou J, Wan J
Sci Adv. 2021; 7(8).
PMID: 33597240
PMC: 7888950.
DOI: 10.1126/sciadv.abd6927.
MYC promotes cancer progression by modulating m A modifications to suppress target gene translation.
Wu G, Suo C, Yang Y, Shen S, Sun L, Li S
EMBO Rep. 2021; 22(3):e51519.
PMID: 33426808
PMC: 7926262.
DOI: 10.15252/embr.202051519.
Biomolecular Condensates and Cancer.
Boija A, Klein I, Young R
Cancer Cell. 2021; 39(2):174-192.
PMID: 33417833
PMC: 8721577.
DOI: 10.1016/j.ccell.2020.12.003.
Identification of Hub Genes in Atypical Teratoid/Rhabdoid Tumor by Bioinformatics Analyses.
Pan X, Liu W, Chai Y, Hu L, Wang J, Zhang Y
J Mol Neurosci. 2020; 70(11):1906-1913.
PMID: 32440821
DOI: 10.1007/s12031-020-01587-8.
Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma.
Feng W, Dean D, Hornicek F, Spentzos D, Hoffman R, Shi H
Ther Adv Med Oncol. 2020; 12:1758835920922055.
PMID: 32426053
PMC: 7222246.
DOI: 10.1177/1758835920922055.
Formation of a structurally-stable conformation by the intrinsically disordered MYC:TRRAP complex.
Feris E, Hinds J, Cole M
PLoS One. 2019; 14(12):e0225784.
PMID: 31790487
PMC: 6886782.
DOI: 10.1371/journal.pone.0225784.